PMDA Stops Increasing Review Staff, Current Review-Time Targets to Remain Unchanged: Chief Executive

PMDA Chief Executive Tatsuya Kondo The Pharmaceuticals and Medical Devices Agency (PMDA) will stop increasing the number of its reviewers this year in order to prevent its review division from falling into a cumulative deficit. Review-time targets will remain at...read more